Brainsway (BWAY) Notes Payables (2018 - 2023)

Brainsway (BWAY) posted quarterly Notes Payables of $106000.0 for Q3 2023, up 3.92% on a QoQ basis from $102000.0 in Q2 2023.

Brainsway (BWAY) Notes Payables (2018 - 2023) Analysis & Trends

Brainsway (BWAY) has reported Notes Payables for 3 consecutive years, with $106000.0 the latest figure, recorded in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn
10	Brainsway	598.04 Mn	538.27 Mn	11.68 Mn

Download Data